Acting against epidemics in low- and middle-income countries

bioMérieux has a longstanding presence in low- and middle-income countries. The Company’s teams are involved in research programs and actions in the field to provide an adequate response to the risk of epidemics.

bioMérieux expanded its corporate donation program to help healthcare facilities in low- and middle-income countries. Our teams, which have been active in these countries for many years, take part in research programs and grass-roots efforts to provide an effective response to infectious risks.

 

Improve diagnostic testing of pediatric fevers

In Southeast Asia, bioMérieux is supporting a multicentric study among children with acute fevers. The study focuses on predicting disease severity.

By providing access to BIOFIRE® FILMARRAY® systems and BIOFIRE® Respiratory Panels (RP2), the study will allow to test for a broader range of pathogens than those currently assessed in the sites. This makes it possible to better understand if the severity biomarkers being studied and the prediction tools being developed perform differently depending on the pathogen responsible for each child’s fever. This study is being overseen by Oxford University in six countries: Bangladesh, Cambodia, Indonesia, Laos, the Philippines and Vietnam.

 

Partnerships in the field of COVID-19

 

  • bioMérieux, alongside 15 other healthcare companies, is participating in the Bill and Melinda Gates Foundation initiative aimed at providing equitable access to COVID-19 diagnostic tests, treatments and vaccines that will help bring an end to the pandemic. 

  • bioMérieux and the Africa Medical Supplies Platform (AMSP) are joining forces to facilitate access to diagnostic solutions to fight the COVID-19 pandemic in Africa. This partnership aims to address the supply shortages experienced by the member states of the African Union by guaranteeing effective, continuous and rapid access to bioMérieux solutions at highly competitive prices.